Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type

Qiuwei Xu1, Jennifer Klees, Jennifer Teyral

  • 1Merck Research Laboratory, Merck & Co., Inc., West Point, PA 19486, USA. qiuwei_xu@merck.com

Analytical Biochemistry
|February 5, 2005
PubMed

Insights

A new quantitative nuclear magnetic resonance (NMR) assay precisely characterizes PedvaxHIB, a vaccine preventing Haemophilus influenzae type b (Hib) disease. This validated NMR method offers a reliable alternative to traditional assays for product release and process monitoring.

Area of Science:

  • Vaccinology
  • Analytical Chemistry
  • Biochemistry

Background:

  • PedvaxHIB is a crucial pediatric vaccine against Haemophilus influenzae type b (Hib).
  • The vaccine's efficacy relies on chemically conjugating Hib capsular polysaccharide to Neisseria meningitidis outer membrane proteins.
  • Accurate characterization of the derivatized polysaccharide is essential for vaccine quality control.

Purpose of the Study:

  • To present and validate a quantitative Nuclear Magnetic Resonance (NMR) methodology.
  • To characterize the derivatized polysaccharide component of PedvaxHIB.
  • To establish a reliable and efficient analytical method for vaccine quality assessment.

Main Methods:

  • Development of a quantitative NMR assay for derivatized polysaccharide.
  • Validation of the NMR assay according to International Council for Harmonisation (ICH) guidelines.
  • Assessment of assay precision, accuracy, specificity, ruggedness, and robustness.

Main Results:

  • The quantitative NMR assay demonstrated high precision (RSD ≤ 1%) and accuracy.
  • The method showed excellent specificity, with no observable matrix interference.
  • The assay proved rugged (RSD < 3% for inter-day/inter-operator variability) and robust to environmental changes.

Conclusions:

  • The validated quantitative NMR assay is a reliable method for product release and process monitoring of PedvaxHIB.
  • This NMR technique offers a more efficient alternative to existing labor-intensive chromatographic and colorimetric methods.
  • The established methodology ensures consistent quality and safety of the Hib vaccine.

Related Concept Videos